Related Experiment Video

Updated: Aug 20, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K

In-hospital complications associated with total artificial heart implantation in the United States between 2004 to

Ahmed K Pasha1, Justin Z Lee2, Hem Desai3

  • 1United Health Services Wilson Hospital in Johnson City NY, USA.

American Journal of Cardiovascular Disease
|November 24, 2022
PubMed

Insights

Total artificial heart (TAH) use has risen in the US. This study found significant complications and mortality rates associated with TAH implants, highlighting the risks of this life-saving device.

Area of Science:

  • Cardiovascular Surgery
  • Medical Device Technology
  • Health Outcomes Research

Background:

  • Total artificial heart (TAH) utilization has seen a notable increase in recent years.
  • Understanding TAH trends, associated complications, and mortality is crucial for patient care.

Purpose of the Study:

  • To evaluate the utilization trends of total artificial hearts in the USA.
  • To assess the morbidity and mortality associated with TAH implantation.

Main Methods:

  • Analysis of a large nationwide inpatient samples (NIS) database.
  • Utilized ICD-9 codes to identify total artificial heart implants.
  • Examined device utilization, complications, and mortality rates from 2004 to 2011.

Main Results:

  • TAH implantation rates increased from 5 in 2004 to 26 in 2011.
  • 22 out of 75 patients (29.3%) experienced mortality.
  • Most common complications included acute renal failure (69.3%), infections (28.0%), and bleeding (14.7%).

Conclusions:

  • Total artificial heart use in the United States has steadily increased.
  • TAH implantation is associated with substantial rates of morbidity and mortality.
Abstract

Keywords:
Artificial heartcomplicationsheart transplantationmortalitytotal artificial hearttransplantation

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
79
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
121
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
20